Evidence map›Paper›PMID 33424267›Full record

ArticleSaudi pharmaceutical journal : SPJ : the official publication of the Saudi Pharmaceutical Society2020

Pharmacological and computer-aided studies provide new insights into

Safaet Alam, Nazim Uddin Emon, Saimon Shahriar, Fahmida Tasnim Richi, Mohammad Rashedul Haque, Mohammad Nazmul Islam, Shahenur Alam Sakib, Amlan Ganguly

Open access · hybridAbstract read
In one paragraph

Article in Saudi pharmaceutical journal : SPJ : the official publication of the Saudi Pharmaceutical Society, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 33 papers.

0numbers the graph read from it
0cells of the map it votes in
33citing papers in PubMed
6.6field-weighted citation impact, top 3% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

33 citing papers in PubMed, 64 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Review
  6. First-time report on compound isolation from twoFrontiers in pharmacology · 2024
    Article
  7. Indian Shot (Journal of inflammation research · 2024
    Article
  8. Article
  9. DecipheringAdvances in pharmacological and pharmaceutical sciences · 2024
    Article
  10. Article
  11. Article
  12. Article
  13. Review
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Biological Functions ofFrontiers in nutrition · 2022
    Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 2 institutions in 1 country.

Safaet AlamDepartment of Pharmaceutical Chemistry, Faculty of Pharmacy, University of Dhaka, Dhaka 1000, Bangladesh.
Nazim Uddin EmonDepartment of Pharmacy, Faculty of Science and Engineering, International Islamic University Chittagong, Chittagong 4318, Bangladesh.
Saimon ShahriarDepartment of Pharmacy, Faculty of Pharmacy, University of Dhaka, Dhaka 1000, Bangladesh.
Fahmida Tasnim RichiDepartment of Pharmacy, Faculty of Pharmacy, University of Dhaka, Dhaka 1000, Bangladesh.
Mohammad Rashedul HaqueDepartment of Pharmaceutical Chemistry, Faculty of Pharmacy, University of Dhaka, Dhaka 1000, Bangladesh.
Mohammad Nazmul IslamDepartment of Pharmacy, Faculty of Science and Engineering, International Islamic University Chittagong, Chittagong 4318, Bangladesh.
Shahenur Alam SakibDepartment of Pharmacy, Faculty of Science and Engineering, International Islamic University Chittagong, Chittagong 4318, Bangladesh.
Amlan GangulyDepartment of Clinical Pharmacy and Pharmacology, Faculty of Pharmacy, University of Dhaka, Dhaka 1000, Bangladesh.
University of Dhaka · BDInternational Islamic University Chittagong · BD

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

5-HT3, 5-hydroxytryptamine 3AnalgesicAntidiarrhealAntioxidantAntitumorASA, acetyl salicylic acidBHT, butylated hydroxytolueneCADD, computer-aided drug discoveryCOX 1, cyclooxygenase-1COX 2, cyclooxygenase-2DPPH, 2,2-diphenyl-1-picryl-hydrazyl-hydrateGABA, gamma-Aminobutyric acidIC50, half maximal inhibitory concentrationIL-1, interleukin-1LC50, Lethal Concentration 50MEMP, methanol extract of Millettia peguensisMillettia peguensisMMP 9, matrix metalloproteinase 9NF-κB, nuclear factor kappa-light-chain-enhancer of activated B cellsRONS, reactive oxygen and nitrogen speciesROS, reactive oxygen speciesTNF-alpha, tumour necrosis factor alpha

Identifiers

PMID33424267
PMCPMC7783235
OpenAlexW3099803339

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.